Variations of 18F-Fluorodeoxyglucose Uptake of Pancreas in Healthy Subjects and the Influential Factors
Wenjie Zhang,Ning Wu,Rong Zheng,Xiaomeng Li,Han Zhang,Ying Liang,Ying Liu,Ping Zhao
DOI: https://doi.org/10.1166/jmihi.2015.1554
2015-01-01
Journal of Medical Imaging and Health Informatics
Abstract:Objective: To investigate F-18-fluorodeoxyglucose (F-18-FDG, hereinafter abbreviated as FDG) uptake levels of the pancreas in healthy subjects undergoing positron emission tomography-computed tomography (PET-CT) scans and the various influential factors. Methods: This study included a total of 261 cases of healthy subjects enrolled from January 2007 to December 2011 who underwent a PET-CT scan at our center. The maximum standardized uptake values (SUVmax) of the pancreatic head, body, and tail were recorded. The subjects were grouped according to their gender, age, body mass index (BMI), history of diabetes, fasting blood glucose level, injection dose, and the time of acquisition after FDG injection. Results: The SUVmax of the pancreatic head, body, and tail of healthy subjects were 1.700 +/- 0.3675, 1.729 +/- 0.4105, and 1.482 +/- 0.3983, respectively. The SUVmax of the pancreatic body and tail of males and the obesity group were higher than those of females and the normal group (including both the normal weight group and the underweight group), and the differences were statistically significant (P < 0.05). Furthermore, the SUVmax of the pancreatic tail in youth and middle-aged groups were higher than those in the older age group, showing a statistically significant difference (F = 3.451, P = 0.033). In addition, the SUVmax of the pancreatic tail in subjects scanned 90 min post-FDG injection were higher than those scanned at <= 90 min, and the difference was statistically significant (F = 8.539, P = 0.000). Multivariate analysis showed that gender and the time of acquisition after the FOG injection were the two most influential factors of the SUVmax of the pancreatic tail. The differences between the groups with and without a history of diabetes, the four groups with different fasting fingertip blood glucose levels (<6.0, 6.0-6.9, 7.0-7.9, and >= 8.0 mmo1/1), and finally the groups injected with various doses of FOG were not statistically significant (P > 0.05) in this study. Conclusions: The SUVmax of the pancreatic head, body, and tail of healthy subjects and the influential factors were preliminarily determined. Gender, age, BMI, and in particular, the time of acquisition after the FDG injection had a greater impact on the FDG uptake levels of pancreas. However, a history of diabetes and fasting fingertip blood glucose values of <8.0 mmol/L had no effect on the FDG uptake levels of pancreas in this study.